|
2000:
January
|
February
|
March
|
April
|
May
|
June
|
July
|
August
|
September
| October
| November..
|
|
|||
|
November
03, 2000 |
2
|
|
||
|
Of Mice and Men We
live in an exciting time of unparalleled breakthroughs in medical
science. Investigation into human genetics and the human genome
promise great things. Undoubtedly, this genetic research will be
very fruitful for bodybuilders. The better we understand the
complexities of our bodies, the better able we will be to control
the anabolic aspects of our biochemistry. The notion that we must
play with the genetic hand dealt us may soon change. On
of the most promising genetic breakthroughs for bodybuilders is
the discovery of the protein leptin. In 1994, researches
investigating obese mice found an obesity gene. The mutation of
this gene resulted in the mice no longer producing leptin (from
the greek Leptos; meaning thin) which researchers concluded was
what lead to the obesity observed in the mice. Of course, the
logical thing to do was to inject our chubby little friends with
exogenous leptin. The results were impressive, the mice's appetite
decreased, their metabolisms increased, and they lost weight.
Furthermore, it was not only mouse leptin that worked, human
leptin produced the same the response in the obese mice. Immediately
everyone was wondering if leptin would produce similar results in
obese humans. Could they have discovered the magic bullet that
would eliminate obesity? A study conducted by Considine, et al.
published in 1996 in the New England Journal of Medicine (NEJM)
examined this question. The conclusions were disappointing to say
the least. They found that obese people had an average of four
times the amount of leptin as normal weight individuals. As there
was a reduction in their fat, leptin levels dropped sharply. This
means that the action of leptin is far more complex in humans then
in mice. Mice suffer from a lack of leptin and could be easily
treated with exogenous leptin injections. But human obesity is not
from a lack of leptin. While a lot of information was learned from
animal research, the application of leptin therapy to humans has
many important and unanswered questions. Fat
(adipose tissue) is not just ugly. It does perform, surprisingly
enough, many important functions that effect metabolic and
endocrine systems. Adipose tissue produces, among other important
proteins, leptin. Leptin exerts a strong effect on the central
nervous system. Leptin interacts with numerous hypothalamic
neuropeptide systems with the end result of influencing eating
patterns and overall energy output[1].
Leptin
is expressed mostly by adipocytes, which supports the theory that
the body senses total fat mass. Cells in the epithelium of the
stomach and in the placenta also secrete smaller amounts of
leptin. Leptin receptors are highly expressed in areas of the
hypothalamus known to be important in regulating body weight.
Leptin is an important component in the long term regulation of
body weight. Recent studies with obese and non-obese humans
demonstrated a strong positive correlation of serum leptin
concentrations with percentage of body fat, and also that there
was a higher concentration of ob (the obesity gene) mRNA in fat
from obese compared to thin subjects. It appears that as
adipocytes increase in size due to accumulation of triglycerides,
they synthesize more and more leptin. In short, leptin appears to
provide the body with an idea of overall nutritional status, no
doubt an important evolutionary precaution. Leptin's
effects on body weight are mediated through effects on
hypothalamic centers that control feeding behavior and hunger,
body temperature and energy expenditure. Daily injections of
recombinant mouse or human leptin into ob/ob mice (the obese
mutant mice without the natural ability to produce leptin with
homozygous recessive genes for obesity) led to a dramatic
reduction in food intake within a few days. In the slightly longer
term the injected leptin lead to roughly a 50% reduction in body
weight within a month. Weight loss resulting from administration
of leptin appears to result from a combination of at least two
fundamental effects: Decreased hunger and food consumption,
mediated at least in part by inhibition of neuropeptide Y
synthesis. Neuropeptide Y is a very potent stimulator of feeding
behavior. The second mode of action was increased energy
expenditure, measured as increased oxygen consumption, higher body
temperature and loss of adipose tissue mass. Even when leptin was
administered to genetically normal mice, there was profound weight
loss and depletion of adipose tissue. There was also an apparent
increase in lean body mass. Let’s
return briefly to how leptin works to reduce fat. Researchers
observed that mice treated with leptin remained at a their new
lean weight long after the treatment ended. To understand how
leptin works I must explain apoptosis. Apoptosis is the
“programmed” death of cells. This is the way in which the body
eliminates damaged or redundant cells. When researchers looked at
what happened to fat cells when leptin was administered it looked
like the cells were dying; they were experiencing apoptosis.
Further research appears to support this conclusion, in mice
leptin causes fat cells to die and does not effect any other
cells. This is an important breakthrough. Fat cells are normally
not destroyed as the result of weight reduction. They merely
shrink in size. Short of liposuction, no method of fat loss
actually reduced the possibility of regaining the weight. It is
therefore theoretically possible to develop a leptin treatment
that permanently causes weight loss by eliminating fat cells from
the body. But it has already been demonstrated that is it hard to
transfer the results of animal tests to human beings. I
would not write an article on some tantalizing new information if
it didn't have practical application to physique or performance
enhancement. Even though there is no leptin therapy available to
humans, research has established correlations between insulin and
insulin-like growth factor and leptin…in humans. Since it is
possible for a bodybuilder to control their insulin and, to some
degree, their IGF-1 levels, control over leptin and therefore
weight loss seems possible. Originally
it was shown that weight loss lowered leptin levels in humans.
However, research into the effects of fasting on leptin produced
evidence that serum leptin concentration is regulated by factors
other then weight loss, namely insulin levels and/or glucose[2].
It appears that circulating leptin may be negatively linked with
serum insulin levels. A marked decrease in serum insulin has been
observed to lower leptin levels[3].
We already know that high insulin levels promote fat storage,
which is why so many bodybuilders use low carbohydrate diets to
stimulate weight loss. The correlation between insulin and leptin
seems to offer further support to the already accepted idea that
it is crucial to control insulin level to facilitate weight loss.
In fact, insulin is appears to be the major regulator of leptin
production in human adipose tissue. IGF-1
is a relatively new drug in bodybuilding circles. Very few people
have used it (real IGF-1 that is) and most people are not
impressed with it. However, IGF-1 appears to play a very important
role in leptin inhibition[4]
in the body, which would suggest IGF-1 to be helpful in losing
weight. Obtaining biologically active IGF-1 may become much
easier, as it has been recently approved for treatment of certain
diseases and is available at some pharmacies. It appears that
IGF-1 may help in weigh reduction along with supporting and
facilitating other anabolic processes in the body. I
think leptin manipulation will play a prominent role in the battle
against obesity. While leptin is perhaps only part of the key, it
certainly shows science that there is a valid genetic rationale
behind weight-gain. Of course, people have been using genetics as
an excuse for years; I’m fat because my parents were fat.
However, as science continues to unlock the mysteries of the human
genetic code, I am confident we will develop a host of vaccines
and inhibitors that will be priceless as far as regulating weight
gain. [1] Havel PJ. Role of Adipose Tissue In Body-Weight Regulation: Mechanisms Regulating Lep production and Energy Balance. Proc Nutr Soc. 2000 Aug:59(3):359-71. [2] Boden G, Chen X, Mozzoli M, Ryan I. Effect of Fasting on Serum Leptin in Normal Human Subjects, J. Clin Edocrinol Metabl. 1996 Sep; 81(9):3419-23. [3] Nakamura T, Nagasaka S, Ishikawa S, Nonaka M, Fujibay ashi K, Saito T, Kusaka I, et al. Crucial Role of Insulin in Leptin maintenance, Endocr J. 2000 Jun, 47(3):359-64 [4] Dagogo-JackS, Franklin SC, Vijayan A, Liu J, Askari H, Miller SB. Recombinant Human Insulin like Growth Factor-1 therapy Decreases P Concentration in Patients With Chronic Renal Insufficiency. Int J Obes Relat Metab Disord. 1998 Nov;22(11):1110-5. |
||||
|
|